评估肌炎特异性及相关性自身抗体的敏感性与特异性:MyoCite队列的子研究
在印度勒克瑙MyoCite队列(2017-2020年)中,比较线性免疫印迹法(LIA)与蛋白免疫沉淀法检测肌炎自身抗体的性能,并以免疫沉淀法为参考标准。免疫沉淀法在56.5%(n=83)患者样本中检出肌炎自身抗体,抗Jo1最常见(n=16;10.9%),其次为抗MDA5(n=14,9.5%)。LIA对 anti-Jo1、anti-PL7、anti-PL12 一致性良好(Cohen's κ 分别为 0.79、0.83、1),但 anti-TIF1γ 一致性差(κ 0.21),总体 59 份(40.1%)样本 LIA 与免疫沉淀法结果不一致。
要点
- 免疫沉淀法在56.5%(n=83)患者样本中检出肌炎自身抗体,抗Jo1最常见(n=16;10.9%)。
- LIA对 anti-Jo1、anti-PL7、anti-PL12 一致性良好(κ 分别为 0.79、0.83、1)。
- anti-TIF1γ 一致性差(κ 0.21),总体 59 份(40.1%)样本 LIA 与免疫沉淀法结果不一致。
核心结论
- LIA可可靠检测 anti-Jo1、anti-PL7、anti-PL12、anti-MDA5 和 anti-NXP-2,但也出现假阳性和假阴性。
- LIA检测其他自身抗体(如 anti-TIF1γ)的效果差。
研究设计与样本
- MyoCite队列为印度勒克瑙成人和幼年特发性炎症性肌病患者的前瞻回顾性数据集(2017-2020年),共147例(125例成人起病,22例幼年起病)血清样本。
- LIA在勒克瑙Sanjay Gandhi研究生医学科学研究所(SGPGIMS)进行,免疫沉淀法在巴斯大学进行,研究者对LIA结果设盲。
- 以免疫沉淀法为参考标准评估LIA性能,计算敏感性、特异性和评定者间一致性。
- 采用单变量和多变量逻辑回归确定特定肌炎特异性自身抗体的临床关联。
主要发现
- 免疫沉淀法在56.5%(n=83)患者样本中检出肌炎自身抗体,抗Jo1最常见(n=16;10.9%),其次为抗MDA5(n=14,9.5%)。
- LIA对 anti-Jo1、anti-PL7 和 anti-PL12 一致性良好,Cohen's κ 分别为 0.79、0.83 和 1。
- anti-TIF1γ 一致性差(Cohen's κ 0.21)。
- 强阳性样本(尤其是肌炎特异性自身抗体)与免疫沉淀法结果更一致。
- 总体59份(40.1%)样本LIA与免疫沉淀法结果不一致,anti-TIF1γ、anti-Ku、anti-PmScl、anti-Mi2 和 anti-SAE 的LIA κ 值范围为0.21至0.60。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Myositis-specific and associated autoantibodies are important biomarkers in routine clinical use. We assessed local testing performance for myositis autoantibodies by comparing line immunoassay (LIA) to protein radio-immunoprecipitation and identifying clinical characteristics associated with each myositis autoantibody in the MyoCite cohort. METHODS: Serum samples from patients within the MyoCite cohort, a well-characterized retro-prospective dataset of adult and juvenile idiopathic inflammatory myopathy (IIM) patients in Lucknow, India (2017-2020), underwent LIA at Sanjay Gandhi Postgraduate Institute of Medical Science (SGPGIMS), Lucknow. Immunoprecipitation of 147 IIM patients' serum samples (125 adult-onset, 22 juvenile-onset) was conducted at the University of Bath, with researchers blind to LIA results. LIA performance was assessed against immunoprecipitation as the reference standard, measuring sensitivity, specificity and inter-rater agreement. Univariate and multivariate logistic regression determined clinical associations for specific myositis-specific autoantibodies. RESULTS: Immunoprecipitation identified myositis autoantibodies in 56.5% (n = 83) of patient samples, with anti-Jo1 (n = 16; 10.9%) as the most common, followed by anti-MDA5 (n = 14, 9.5%). While LIA showed good agreement for anti-Jo1, anti-PL7 and anti-PL12 (Cohen's κ 0.79, 0.83 and 1, respectively), poor agreement was observed in other subgroups, notably anti-TIF1γ (Cohen's κ 0.21). Strongly positive samples, especially in myositis-specific autoantibodies, correlated more with immunoprecipitation results. Overall, 59 (40.1%) samples exhibited non-congruence on LIA and immunoprecipitation, and κ values for LIAs for anti-TIF1γ, anti-Ku, anti-PmScl, anti-Mi2 and anti-SAE ranged between 0.21 and 0.60. CONCLUSION: While LIA reliably detected anti-Jo1, anti-PL7, anti-PL12, anti-MDA5 and anti-NXP-2, it also displayed false positives and negatives. Its effectiveness in detecting other autoantibodies, such as anti-TIF1γ, was poor.
引用
- Loganathan A, Gupta L, Rudge A, et al. Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort. Rheumatology (Oxford). 2024. PMID: 38479813. doi:10.1093/rheumatology/keae167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。